Myeloid cell–specific deletion of the key glycolytic enzyme 6-Phosphofructo-2-kinase significantly alleviates PAH phenotypes in mice and reduces levels of growth factors and pro-inflammatory cytokines, clearly demonstrating the critical pathogenic role of glycolysis in PAH. This evidence concerns the gene PFKFB3 and pulmonary arterial hypertension.